DURATION-8 Randomized Controlled Trial 104-Week Results—Once-Weekly Exenatide (ExQW) plus Once-Daily Dapagliflozin (DAPA) vs. ExQW or DAPA Alone
Keyword(s):
2011 ◽
Vol 13
(3)
◽
pp. 268-275
◽
Keyword(s):
2007 ◽
Vol 39
(10)
◽
pp. 896-901
◽
2006 ◽
Vol 117
(4)
◽
pp. 802-809
◽
2001 ◽
Vol 85
(7)
◽
pp. 793-798
◽
Keyword(s):
2015 ◽
Vol 55
(7)
◽
pp. 831-838
◽